 Subjects -> PHARMACY AND PHARMACOLOGY (Total: 575 journals)
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z | | The end of the list has been reached or no journals were found for your choice. |
|
|
- Addendum: Dexlansoprazole for GERD
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: admin
Abstract: Date: May 16, 2022 Issue #: 1650 Summary: A reader commented that our recent article onDrugs for GERD and Peptic Ulcer Disease did notinclude enough information on dexlansoprazole(Dexilant, and generics), a proton pump inhibitor(PPI) claimed to provide "all-day and all-night relieffrom heartburn". Dexlansoprazole recently becameavailable generically, but it is much more expensivethan other generic PPIs.
PubDate: Fri, 29 Apr 2022 11:59:14 +000
- In Brief: Higher-Dose Semaglutide (Ozempic) for Type 2 Diabetes
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: admin
Abstract: Date: May 16, 2022 Issue #: 1650 Summary: The FDA has approved a higher-dose injectableformulation of the long-acting glucagon-likepeptide-1 (GLP-1) receptor agonist semaglutide(Ozempic) for treatment of type 2 diabetes in adults.A single SC injection of the new 8 mg/3 mLformulation delivers 2 mg of semaglutide.
PubDate: Fri, 29 Apr 2022 11:55:12 +000
- Delayed-Release Budesonide (Tarpeyo) for Primary Immunoglobulin A
Nephropathy-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: admin
Abstract: Date: May 16, 2022 Issue #: 1650 Summary: The FDA has approved Tarpeyo (Calliditas), a delayed-releasecapsule formulation of the corticosteroidbudesonide, to reduce proteinuria in adults withprimary immunoglobulin A nephropathy (IgAN; alsocalled Berger's disease) who are at risk of rapiddisease progression. It is the fi rst drug to be approvedin the US for this indication. Oral formulationsof budesonide have been available for years fortreatment of inflammatory bowel disease.
PubDate: Fri, 29 Apr 2022 11:47:43 +000
- In Brief: OTC Alcaftadine (Lastacaft Once Daily Relief) for Allergic
Conjunctivitis-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: admin
Abstract: Date: May 16, 2022 Issue #: 1650 Summary: The ophthalmic H1-antihistamine alcaftadine 0.25%,which has been available by prescription since 2011for use in patients with allergic conjunctivitis, is nowavailable without a prescription as Lastacaft OnceDaily Relief (Allergan) for temporary relief of itchy eyesdue to pollen, ragweed, grass, animal hair, and danderin adults and children ≥2 years old. It is the thirdophthalmic antihistamine to be approved for over-the-counter(OTC) use (see Table 1).
PubDate: Tue, 19 Apr 2022 13:51:51 +000
- A Three-Antigen Hepatitis B Vaccine (PreHevbrio)
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: admin
Abstract: Date: May 16, 2022 Issue #: 1650 Summary: The FDA has licensed PreHevbrio (VBI Vaccines), arecombinant, 3-antigen, 3-dose hepatitis B vaccine,for the prevention of infection caused by all knownsubtypes of hepatitis B virus (HBV) in adults. It hasbeen available in Israel since 2000.
PubDate: Tue, 05 Apr 2022 13:57:56 +000
- Tretinoin/Benzoyl Peroxide Cream (Twyneo) for Acne
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: admin
Abstract: Date: May 16, 2022 Issue #: 1650 Summary: The FDA has approved Twyneo (Galderma), a creamcontaining the retinoid tretinoin and the oxidizingagent benzoyl peroxide, for once-daily topicaltreatment of acne in patients ≥9 years old.
PubDate: Tue, 05 Apr 2022 13:56:35 +000
|
Subscription journal
